STUART ARNOLD FINE
Medical Practice in Northbrook, IL
License number
Pennsylvania MD060231L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Northbrook, IL 60062
Pennsylvania
Pennsylvania
Professional information
Combinations Of Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007020, Sep 6, 2007
Filed:
Jan 24, 2007
Appl. No.:
11/657401
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 33/24
US Classification:
424646000, 424655000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2005023, Oct 20, 2005
Filed:
Mar 23, 2005
Appl. No.:
11/088272
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K038/28, A61K031/555, A61K031/426, A61K031/175, A61K031/155
US Classification:
514003000, 514184000, 514369000, 514592000, 514635000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007019, Aug 23, 2007
Filed:
Jan 22, 2007
Appl. No.:
11/656351
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 38/28, A61K 31/555, A61K 31/155, A61K 31/4439, A61K 31/426, A61K 31/192
US Classification:
514003000, 514184000, 514342000, 514369000, 514025000, 514594000, 514635000, 514569000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics
US Patent:
2005023, Oct 20, 2005
Filed:
Mar 23, 2005
Appl. No.:
11/088273
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K038/28, A61K031/555, A61K031/426, A61K031/175, A61K031/155
US Classification:
514003000, 514184000, 514369000, 514592000, 514635000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007019, Aug 23, 2007
Filed:
Jan 5, 2007
Appl. No.:
11/650343
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 38/28, A61K 31/7034, A61K 31/555, A61K 31/155, A61K 31/4439, A61K 31/426, A61K 31/17, A61K 31/19
US Classification:
424646000, 514594000, 514003000, 514342000, 514369000, 514635000, 514569000, 514184000, 514025000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2005028, Dec 22, 2005
Filed:
May 31, 2005
Appl. No.:
11/141265
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K031/555, A61K031/175, A61K031/155, A61K031/426
US Classification:
514184000, 514592000, 514635000, 514369000, 514003000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Dietary Supplement And Method Of Treatment For Diabetic Control
US Patent:
5962030, Oct 5, 1999
Filed:
Nov 5, 1997
Appl. No.:
8/964814
Inventors:
Stuart A. Fine - Northbrook IL
Assignee:
Akesis Pharmaceuticals, Inc. - La Jolla CA
International Classification:
A61K 3326, A61K 3324, A61K 3314, A61K 3306, A61K 3160
US Classification:
424646
Abstract:
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2007016, Jul 12, 2007
Filed:
Nov 22, 2006
Appl. No.:
11/603931
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
Assignee:
Akesis Pharmaceuticals - La Jolla CA
International Classification:
A61K 38/28, A61K 31/555, A61K 31/426, A61K 31/192, A61K 31/155, A61K 31/17
US Classification:
514003000, 514184000, 514594000, 514635000, 514369000, 514568000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Combinations Of Chromium Or Vanadium With Antidiabetics For Glucose Metabolism Disorders
US Patent:
2006000, Jan 5, 2006
Filed:
Jun 1, 2005
Appl. No.:
11/142807
Inventors:
Stuart Fine - Northbrook IL, US
Kevin Kinsella - La Jolla CA, US
Kevin Kinsella - La Jolla CA, US
International Classification:
A61K 31/555, A61K 31/4439, A61K 31/426, A61K 31/175, A61K 31/155
US Classification:
514184000, 514369000, 514340000, 514592000, 514635000
Abstract:
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Dietary Supplement And Method Of Treatment For Diabetic Control
US Patent:
6203819, Mar 20, 2001
Filed:
Mar 19, 1999
Appl. No.:
9/272819
Inventors:
Stuart A. Fine - Northbrook IL
Assignee:
Akesis Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 3326, A61K 3324, A61K 3314, A61K 3160, A61K 31355
US Classification:
424646
Abstract:
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.